Connect with us

International

The US ambassador says goodbye to Mexico without regretting “anything” despite bilateral tension

The US ambassador to Mexico, Ken Salazar, said goodbye on Monday with a last message in which he assured that he “does not regret anything”, amid bilateral tensions over Washington’s criticism of judicial reform and the production of fentanyl in the country.

“I don’t regret anything. I’m leaving better, feeling that we have a strong and good job, which should be carried out between the two countries more frequently,” he said at a final press conference before leaving the position of ambassador, which he held since 2021 when Democratic President Joe Biden appointed him.

“In more than three years and more than 120 visits, I toured the 32 states of Mexico (…) Our countries have lived a historical cooperation consolidating North America as the main economic power,” he stressed.

The president-elect of the United States, the Republican Donald Trump, who will take office on January 20, has announced as his candidate for ambassador of the country to Mexico the retired colonel Ronald Johnson, a position for which he must be approved by the US Senate.

Salazar, 69, began his stay in Mexico showing great closeness to President Andrés Manuel López Obrador (2018-2024), but over time the relationship became tense until he ended with direct criticism of the Mexican government’s security policy and the judicial reform that the popular election of judges seeks.

Advertisement
20260101_dengue_cubeta_728x90
previous arrow
next arrow

The ambassador commented on the controversy surrounding fentanyl, causing a public health crisis due to a wave of overdose deaths in the United States, and that Washington considers to be produced in Mexico and China, so he has redoubled the calls to these countries to fight its production.

“I know what happens, that there is fentanyl in Mexico and I also know that it is produced here,” he said.

However, he indicated that it is “a debate, which occurs or does not occur, does not lead us where we have to go” and called on the Mexican government to maintain collaboration with the United States on this matter.

After Salazar’s departure, the business manager, Mark Johnson, is in charge of the US embassy in Mexico.

Regarding the proposals for mass deportations and tightening of Trump’s immigration policies, the outgoing ambassador acknowledged that there will be “changes” and “fear” among the migrant population in the United States.

Advertisement
20260101_dengue_cubeta_728x90
previous arrow
next arrow

It is estimated that about half of the 11 million undocumented people in the United States are Mexicans.

Last week, the president of Mexico, Claudia Sheinbaum, proposed that this month there be a meeting between the foreign ministers of Latin America to address the challenges of migration before Trump’s arrival at the White House.

Sheinbaum, who has said she is prepared to receive the deported Mexicans, has reiterated “the insistence on the United States that repatriation be made to the different countries of origin,” instead of expelling them all to Mexico.

Continue Reading
Advertisement
20260101_dengue_balde_300x250

International

India Approves New Dengue Vaccine as Global Cases Continue to Rise

India has approved a new dengue vaccine as health authorities seek to strengthen prevention efforts against a mosquito-borne viral disease that affects millions of people worldwide every year.

According to the World Health Organization (WHO), half of the global population is currently at risk of contracting dengue, which causes between 100 million and 400 million infections annually.

Since 2021, India has recorded more than one million dengue cases, including at least 1,500 deaths.

The virus can cause high fever, severe headaches, muscle pain, nausea, skin rashes and, in rare cases, internal bleeding and death.

The vaccine, authorized by India’s Central Drugs Standard Control Organization (CDSCO), was developed by Japanese pharmaceutical company Takeda. The Indian Health Ministry said the vaccine is recommended in two doses for people between 4 and 60 years old.

Advertisement
20260101_dengue_cubeta_728x90
previous arrow
next arrow

The treatment has already been approved by health authorities in around 40 countries worldwide.

Meanwhile, Indian pharmaceutical company Panacea Biotec has begun the final phase of clinical trials for a single-dose dengue vaccine, aiming to provide another prevention option against the disease.

Brazil recently announced the suspension of the use of another single-dose dengue vaccine developed in the country after two suspected deaths were reported.

Continue Reading

International

U.S. Sends First Humanitarian Aid Flight to Cuba Amid Ongoing Tensions Between Both Governments

The United States announced Tuesday the dispatch of a humanitarian aid flight to Cuba as part of a $100 million assistance package proposed by Secretary of State Marco Rubio in May.

The flight departed from Miami with the support of Catholic Relief Services, according to a statement from the U.S. State Department.

The administration of President Donald Trump, which has maintained restrictions on oil supplies to the island and tightened sanctions against the Cuban government, had initially announced humanitarian assistance in November following the devastating impact of Hurricane Melissa.

In February, amid rising tensions between Washington and Havana, Rubio announced an increase in aid while continuing to criticize the Cuban government.

The U.S. secretary of state accused Cuba’s communist authorities of obstructing the distribution of assistance. Washington has insisted that the aid be delivered through the Catholic Church to ensure it reaches Cuban citizens directly.

Advertisement
20260101_dengue_cubeta_728x90
previous arrow
next arrow

The Cuban government, meanwhile, has blamed the U.S. oil blockade for making the distribution of humanitarian assistance significantly more difficult.

The aid shipment comes as relations between the two countries remain strained, with disagreements continuing over sanctions, energy supplies and the management of humanitarian support.

Continue Reading

International

Controversial Pesticide Law Passes in France, Sparking Ecological Concerns and Ministerial Fallout

The French Parliament on Tuesday approved a highly controversial agricultural law that allows certain farmers to use two pesticides considered harmful to bees, substances that had been banned in France but remain authorized in the European Union.

After the National Assembly, the lower house of Parliament, approved the agricultural bill in the early hours of Tuesday, the Senate gave its final approval with a vote of 214 in favor and 111 against, officially adopting the measure.

Following the decision to reintroduce the use of acetamiprid and flupyradifurone, the office of Environment Minister Monique Barbut announced that she would soon submit her resignation.

Supporters of the measure argue that French producers of sugar beets, apples and hazelnuts need access to these insecticides — banned in France since 2018 and 2019, respectively — to remain competitive with European farmers in other countries where the products are still allowed.

Opponents, including environmental groups, argue that the substances pose serious risks to bees and could also threaten human health.

Advertisement
20260101_dengue_cubeta_728x90
previous arrow
next arrow

“Let us be proud of the work that has been done,” said Senator Laurent Duplomb of the conservative Republicans party, one of the main supporters of the measure.

The vote came after France’s Constitutional Council, the country’s highest court, struck down a previous attempt last year to bring back acetamiprid, ruling that the measure could pose risks to human health. That decision followed a petition signed by more than two million people opposing the pesticide’s reintroduction.

The previous bill had also been promoted by Duplomb, who argued that French agriculture needed additional tools to compete in international markets.

Continue Reading

Trending

Central News